11-95979927-G-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_032427.4(MAML2):c.2492C>A(p.Ala831Asp) variant causes a missense change. The variant allele was found at a frequency of 0.0000198 in 1,613,702 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_032427.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAML2 | NM_032427.4 | c.2492C>A | p.Ala831Asp | missense_variant | 5/5 | ENST00000524717.6 | NP_115803.1 | |
MAML2 | XM_011543023.4 | c.2051C>A | p.Ala684Asp | missense_variant | 5/5 | XP_011541325.1 | ||
MAML2 | XM_047427710.1 | c.1808C>A | p.Ala603Asp | missense_variant | 5/5 | XP_047283666.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAML2 | ENST00000524717.6 | c.2492C>A | p.Ala831Asp | missense_variant | 5/5 | 1 | NM_032427.4 | ENSP00000434552.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152174Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000281 AC: 7AN: 248680Hom.: 0 AF XY: 0.0000371 AC XY: 5AN XY: 134896
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1461528Hom.: 0 Cov.: 32 AF XY: 0.0000206 AC XY: 15AN XY: 727026
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152174Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74334
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 09, 2024 | The c.2492C>A (p.A831D) alteration is located in exon 5 (coding exon 5) of the MAML2 gene. This alteration results from a C to A substitution at nucleotide position 2492, causing the alanine (A) at amino acid position 831 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at